Use of Fish Skin Graft (FSG) to Improve Wound Healing and Expedite Discharge at a County Safety-net Hospital
- Conditions
- Surgical Wound
- Registration Number
- NCT06910189
- Lead Sponsor
- The University of Texas Health Science Center, Houston
- Brief Summary
The purpose of this study is to estimate the effect of FSG (Kerecis) on hospital length of stay among adult patients with surgical wounds of at least 40cm2 requiring surgical debridement
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 96
- Has wound greater than or equal to 40cm2 requiring surgical debridement
- Agreeable to follow up period of up to 1 year
- Patients with wounds that do not require surgical debridement.
- Patients with a known allergy or other sensitivity to fish material
- Patients who are deemed unlikely to follow up (e.g., patients who live out of state).
- Patients in police custody/incarcerated.
- Patients unable to communicate in either Spanish or English.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Hospital length of stay from time of admission to time of discharge (about 3 days from date of surgery)
- Secondary Outcome Measures
Name Time Method Number of participants that have recurrent surgical site infection Upto 1 year after surgery Number of participants that require reoperation Upto 1 year after surgery Time to total wound healing From end of surgery to upto 1 year after surgery Number of participants that need skin graft Upto 1 year after surgery time from original surgery with placement of wound vac until the patient gets a skin graft upto 1 year after surgery time to return to work From discharge (about 3 days from date of surgery) upto 1 year after surgery Number of participants that need wound vac after discharge At discharge (about 3 days from date of surgery) Inpatient hospital costs At discharge (about 3 days from date of surgery) financial toxicity experienced by patients as assessed by the COST - FACIT survey 6 months after discharge This is a 12 item questionnaire and each is scored from 0( not at all) to 4(very much), for a maximum score of 48, higher score indicating lower financial toxicity.
financial toxicity experienced by patients as assessed by the COmprehensive Score for financial Toxicity (COST)-Functional Assessment of Chronic Illness Therapy (FACIT) survey 12 months after discharge This is a 12 item questionnaire and each is scored from 0( not at all) to 4(very much). Questions 2,3,6 and 7 are reverse scored for a maximum score of 48, higher score indicating lower financial toxicity.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
The University of Texas Health Science Center at Houston
🇺🇸Houston, Texas, United States